Vadim Vyacheslavovich Berestov

Vadim Vyacheslavovich Berestov

Auto-generated profile, based on publicly available information

Vadim Vyacheslavovich Berestov

Federal Center of Brain and Neurotechnologies of Federal Medical Biological Agency of Russia, Moscow, Russian Federation

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
LDL. Détraz
L. Détraz
KOK. Orlov
K. Orlov
VBV. Berestov
V. Berestov
VBVladimir Borodetsky
Vladimir Borodetsky
ARA. Rouchaud
A. Rouchaud
CMC. Mounayer
C. Mounayer
BACKGROUND AND PURPOSE: Dural AVFs located in the posterior fossa are a rare entity. The objectives of the study were to analyze the anatomy of dural AVFs, their endovascular treatment strategies, and clinical outcomes. MATERIALS AND METHODS: Two centers retrospectively selected patients treated between January 2009 and June 2018 having posterior fossa dural AVFs. We collected patient demographics, clinical presentation, arterial and venous outflow anatomy of the dural AVFs, and treatment outcomes. RESULTS: Twenty-six patients treated endovascularly for posterior fossa dural AVFs, type III, IV, or V, were included. One hundred percent of the dural AVFs were occluded. A transarterial approach was performed in 23 dural AVFs (88.5%); a combined transarterial and transvenous approach, for 2 dural AVFs (7.7%); and a transvenous approach alone, for 1 dural AVF (3.8%). The middle meningeal artery was the most common artery chosen to inject embolic liquid (46%, 12/26). Procedure-related morbidity was 15.4% at 24 hours, 7.7% at discharge, and 0% at 6 months. Procedure-related mortality was 0%. CONCLUSIONS: Endovascular treatment offers high occlusion rates for posterior fossa dural AVFs with low morbidity and mortality rates. The arterial approach is the first-line preferred approach, even if a transvenous or combined approach would be a safe and effective option for patients with favorable anatomy. Twenty-six patients treated endovascularly for posterior fossa dural AVFs, type III, IV, or V, were included in this study. One hundred percent of the dural AVFs were occluded. A transarterial approach was performed in 23 dural AVFs; a combined transarterial and transvenous approach, in 2 dural AVFs; and a transvenous approach alone, in 1 dural AVF. The middle meningeal artery was the most common artery chosen to inject embolic liquid (12/26). Procedure-related morbidity was 15.4% at 24 hours, 7.7% at discharge, and 0% at 6 months. Procedure-related mortality was 0%. The authors conclude that endovascular treatment offers high occlusion rates for posterior fossa dural AVFs with low morbidity and mortality rates.

3 September 2020 in Innovative Medicine of Kuban
Verified
Journal Article
Open access
PDF file
SZS. A. Zhade
S. A. Zhade
MPM. E. Pershin
M. E. Pershin
АБА. И. Белый
А. И. Белый
AFA. N. Fedorchenko
A. N. Fedorchenko
VBV. V. Berestov
V. V. Berestov
GMG. G. Muzlaev
G. G. Muzlaev
The article discusses the etiology, pathogenesis, classification, principles of diagnosis and tactics of surgical treatment of dural arteriovenous fistulas. Two clinical cases of successful treatment of patients with symptomatic dural arteriovenous fistulas are presented.

26 August 2021 in Siberian Scientific Medical Journal
Verified
Journal Article
Open access
PDF file
VBV. V. Berestov
V. V. Berestov
KOK. Yu. Orlov
K. Yu. Orlov
AKAlexey Krivoshapkin
Alexey Krivoshapkin
НСН. В. Стрельников
Н. В. Стрельников
ASA. I. Somova
A. I. Somova
LKL. M. Kirillov
L. M. Kirillov
The necessity of quick surgical treatment of acute ruptured cerebral aneurysms was demonstrated in large studies by the ISAT and ISUIA, which also proved the advantage of the endovascular method over the surgical one. Ballonassistence is widely used in treatment of aneurysms with wide neck and unfavorable vascular anatomy, but the radicality of the treatment is insufficient. The aim of this study was to demonstrate the efficacy and safety of stent-assisted embolization of «acute» cerebral aneurysms. Material and methods. A retrospective analysis of the treatment of 234 patients with «acute» cerebral aneurysms was carried out. Results. Only coils were used in 40.6 % of cases (n = 95), balloon-assistance, in 40.2 % of cases (n = 94), and stent-assistance, in 19.2 % of cases (n = 45). There were 11.5 % (n = 27) clinically significant complications. Total aneurysm occlusion (Raymond-Roy I) was achieved in 187 cases (79.9 %); the radicality at the control examination was 67.1 % (157 patients). Discussion. The radicality of the treatment with stents was slightly higher then with balloons and coils at the end of operation (84.4 %, n = 38 and 78.8 %, n = 149, p > 0.05), but it was significantly higher at the control examination (80.0 %, n = 36 and 60.8 %, n = 115, respectively, p <0.05). Also, we had no statistically significant difference of the complication rate in the «stent» and «no stent» groups; therefore, the clinical outcomes of endovascular treatment of cerebral aneurysms did not depend on the choice of treatment method. Conclusions. Intracranial stents allow achieving good results of the embolization of complex aneurysms in the acute period of intracranial hemorrhage without increasing the risk of surgical treatment.

15 July 2022 in Siberian Journal of Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
NON. R. Obedinskaya
N. R. Obedinskaya
VBV. V. Berestov
V. V. Berestov
KOK. Yu. Orlov
K. Yu. Orlov
AGA. M. Gornostaeva
A. M. Gornostaeva
AKA. M. Korostyshevskaya
A. M. Korostyshevskaya
Pial arteriovenous fistula (PAVF) is an extremely rare type of intracranial vascular congenital anomalies. The presented clinical case is a unique example of intrauterine diagnosis of PAVF using fetal MRI at 30 weeks of gestation, which allowed successful surgical treatment in the early neonatal period. The case demonstrates the capabilities of fetal MRI in the diagnosis of PAVF and estimation of accompanying brain changes, which are fully consistent with the results of postnatal cerebral angiography. Based on neuroimaging data, endovascular embolization of the fistula with detachable microcoils was successfully performed on the 2nd day of the child’s life. A good neurologic outcome of the surgery was stated. Taking into account the known unfavorable outcome of PAVF in the case of untimely surgical treatment, this observation demonstrates the need to use fetal MRI for prenatal differential diagnosis of vascular malformations in order to reduce the risk of possible complications and mortality in the early neonatal period.

30 July 2023
Verified
Conference Paper
Open access
PDF file
VBV Berestov
V Berestov
KOK Orlov
K Orlov
NSN Strelnikov
N Strelnikov
ABA Brusyanskaya
A Brusyanskaya
ASA Somova
A Somova
Background Pediatric arteriovenous malformations (AVM) and pial/dural arteriovenous fistulas (AVF) are rare but life-threatening diseases that can lead to congestive heart failure and hemorrhagic stroke in newborns and pediatric patients. The pronounced shunting in these conditions is associated with early complications and necessitates aggressive surgical management. Materials and Methods For 10 years, our team at the Meshalkin National Medical Research Center and Federal Center of Brain Research and Neurotechnologies has accumulated extensive experience in endovascular treatment of pediatric patients with congenital cerebrovascular pathology; we have conducted a total of 158 procedures in 70 patients, including 18 endovascular interventions in 16 newborns. Overall complication rate was 14,3% (10 pts) with 10,0% (7 pts) morbidity rate. Total cure was achieved in 41 patients (58,6%). Results Based on our experience of using various embolic agents, we believe that cyanoacrylate compositions are the most suitable for AVF embolization. Due to their adhesive properties, they allow for controlled and effective occlusion of high-flow fistulas (more than 70% of procedures in our series of cases). Non-adhesive compositions are effective for final embolization of residual small feeders (28,5%).In one case (AVF formed direct communication between basilar artery and dilated deep cerebral vein) we have performed subtotal embolization of the AVF by 0,020’’ coils, which led to progressive thrombosis of the fistula with restoration of normal arterial blood flow. The patient was discharged 18 days after surgery, and MRI at 1.5 and 6 months showed the absence of blood flow through the fistula and satisfactory condition of the infant without physical and mental developmental delay. Anteroposterior (A, C) and lateral (B, D) vertebral angiograms before (A, B) and after (C, D) AVF embolization in the same phase of contrast enhancement. A significant improvement in contrast enhancement of cerebral vessels and a pronounced decrease in blood flow through the fistula are observed Conclusion Endovascular treatment of pediatric arteriovenous shunts is extremely difficult and associated with high risks of complications. However, excellent clinical results can be achieved in specialized clinics. The choice of embolic agent should depend on the hemodynamic load of the pathological blood flow. Disclosures V. Berestov: None. K. Orlov: None. N. Strelnikov: None. A. Brusyanskaya: None. A. Somova: None.

30 July 2023
Verified
Conference Paper
Open access
PDF file
KOK Orlov
K Orlov
NSN Strelnikov
N Strelnikov
VBV Berestov
V Berestov
ASA Somova
A Somova
ABA Brusyanskaya
A Brusyanskaya
Background Endovascular approach is one of the ways to successfully treat cerebral aneurysms. Currently, there are various techniques and devices to increase the radicality of endovascular treatment. Despite the variety of available techniques, in recent years, flow diverts (FDs) have been increasingly preferred as a method for treating cerebral aneurysms. Materials and Methods From January 2011 to March 2023 at E.Meshalkin National Medical Research Center, Novosibirsk, and Federal Center of Brain Research and Neurotechnologies, Moscow, 3803 endovascular operations to treat cerebral aneurysms were performed. 1009 (26.4%) FDs were implanted, and in the rest of the cases, the patients were treated using other embolization techniques. A retrospective analysis of the results obtained with FDs was carried out. Results The technical success was 96.8%. The frequency of at which FDs were preferred to other techniques to treat cerebral aneurysms for 2011-2015 was 16.7% (n=164), and 28.1% (n=489) for 2016-2020. In 2021, FDs were implanted in 29.6% (n=149) of cases. From 2022 to March 2022, this technique was used in 36.4% (n=227) of the operations performed. According to the control studies (at median 9 months), total occlusion in the entire series has been achieved in 78.1% of cases (n=788), while some patients (n=164) are still waiting for their controls to be performed. For all FD interventions, a severe neurological deficit has comprised 1.09%, and mortality 0.4%. Conclusion FD implantation is an effective and safe endovascular technique to treat cerebral aneurysms. Our experience shows that in recent years there has been a trend towards an increase in the number of implanted FDs if compared to other applied techniques without reducing the radicality and safety of endovascular treatment. The variety of currently available FDs, their technical capabilities, and improved delivery catheters make the embolization more convenient, reduce the operation time as well as the radiation and contrast loads. However, despite FD’s apparent simplicity, the need for antiplatelet therapy in the postoperative period and the restrictions on their use in the distal parts of the Willis circle and bifurcation aneurysms, not to mention their high price, still limit application of this treatment method, so further studies are required to expand the indications for the use of FDs. Disclosures K. Orlov: None. N. Strelnikov: None. V. Berestov: None. A. Somova: None. A. Brusyanskaya: None.